Lonza Group AG (LON:0QNO)
London · Delayed Price · Currency is GBP · Price in CHF 505.38
-1.52 (-0.30%)
Feb 12, 2026, 5:08 PM GMT
Lonza Group AG Market Cap
Lonza Group AG has a market cap or net worth of 33.82 billion as of February 12, 2026. Its market cap has decreased by -10.47% in one year.
Market Cap
33.82B
Enterprise Value
37.16B
Revenue
6.12B
Ranking
n/a
PE Ratio
38.03
Stock Price
505.38
Market Cap Chart
Since November 1, 1999, Lonza Group AG's market cap has increased from 2.30B to 33.82B, an increase of 1,367.81%. That is a compound annual growth rate of 10.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 33.82B | -4.63% |
| Dec 30, 2025 | 35.46B | 4.00% |
| Dec 30, 2024 | 34.10B | 39.19% |
| Dec 29, 2023 | 24.50B | -18.81% |
| Dec 30, 2022 | 30.17B | -34.20% |
| Dec 30, 2021 | 45.85B | 30.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 218.75B |
| GSK plc | 86.64B |
| Haleon | 34.95B |
| Smith & Nephew | 10.82B |
| Convatec Group | 4.41B |
| Hikma Pharmaceuticals | 3.41B |
| Genus | 2.04B |
| HUTCHMED (China) | 1.82B |